Citation Impact
Citing Papers
Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy
2008
Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells
2008
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity In vivo
2006
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Impact of urgent resuscitative surgery for life-threatening torso trauma
2016
Local IL-21 Promotes the Therapeutic Activity of Effector T cells by Decreasing Regulatory T Cells Within the Tumor Microenvironment
2008
Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers
2008
Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus–transformed B cells
2004
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma
1999
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
1998 StandoutNature
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Goal-directed resuscitation in the prehospital setting
2013
A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance
2006
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited
2009
Surgical management for the first 48 h following blunt chest trauma: state of the art (excluding vascular injuries)
2014
Coordinated regulation of myeloid cells by tumours
2012 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
CT of Major Vascular Injury in Blunt Abdominopelvic Trauma
2016
Colorectal cancer
2013 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Indications for embolization in a French level 1 trauma center
2016
Conditional Immortalization of Human B Cells by CD40 Ligation
2008
Prehospital Intravenous Fluid Administration Is Associated With Higher Mortality in Trauma Patients
2010
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Membrane vesicles as conveyors of immune responses
2009 Standout
Biodistribution and function of extracellular miRNA-155 in mice
2015 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules
2005
MYCN as a target for cancer immunotherapy
2007
Principles of adoptive T cell cancer therapy
2007
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Trauma center variation in splenic artery embolization and spleen salvage
2013
How regulatory T cells work
2008 Standout
Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies
2014
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
1999
Epstein–Barr virus: 40 years on
2004 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Eicosanoids and cancer
2010 Standout
Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigens
2001
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells
2000
The Immune Revolution: A Case for Priming, Not Checkpoint
2018
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages
2014
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Multiple sclerosis
2002 Standout
CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
2012
Synthetic Messenger RNA as a Tool for Gene Therapy
2006
Chimeric Receptor mRNA Transfection as a Tool to Generate Antineoplastic Lymphocytes
2009
In vivoblockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
1999 StandoutNobel
A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic Protein 1 in lymphopoiesis and innate immunity
2008 StandoutNobel
Development of anti-PAX3 immune responses; a target for cancer immunotherapy
2007
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition
2006
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
1998
Hypothermia for pediatric refractory status epilepticus
2013
Anergy Induction by Dimeric TCR Ligands
2001
Adverse events associated with ERCP
2016 Standout
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
2000
Induction of Exosome Release in Primary B Cells Stimulated via CD40 and the IL-4 Receptor
2008
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
2000 StandoutNobel
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
2002
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.
1996
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Sampling‐Based versus Design‐Based Uncertainty in Regression Analysis
2020 StandoutNobel
Right‐to‐Carry Laws and Violent Crime: A Comprehensive Assessment Using Panel Data and a State‐Level Synthetic Control Analysis
2019
Identification of Pancreatic Cancer Stem Cells
2007 Standout
The role of B7 family molecules in hematologic malignancy
2012
Responses to Human CD40 Ligand/Human Interleukin-2 Autologous Cell Vaccine in Patients with B-Cell Chronic Lymphocytic Leukemia
2005
Cross-presentation of tumor antigens by bone marrow–derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression
2001
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1
2004
Part 8: Post–Cardiac Arrest Care
2015 Standout
Utility of Chest Computed Tomography after a “Normal” Chest Radiograph in Patients with Thoracic Stab Wounds
2015
Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma
1999
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Follicular Lymphoma Intratumoral CD4+CD25+GITR+ Regulatory T Cells Potently Suppress CD3/CD28-Costimulated Autologous and Allogeneic CD8+CD25− and CD4+CD25− T Cells
2007
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Efficient Identification of Novel Hla-A*0201–Presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen Prame by Proteasome-Mediated Digestion Analysis
2001
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Damage Control Resuscitation
2014
Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells
2000
Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells
2000
The BB1 Monoclonal Antibody Recognizes Both Cell Surface CD74 (MHC Class II-Associated Invariant Chain) as Well as B7-1 (CD80), Resolving the Question Regarding a Third CD28/CTLA-4 Counterreceptor
1998
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 StandoutNobel
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Works of Mark J. Seamon being referenced
The use of emergency department thoracotomy for traumatic cardiopulmonary arrest
2012
Prehospital Procedures Before Emergency Department Thoracotomy: “Scoop and Run” Saves Lives
2007
Blunt abdominal aortic injury
2014
Evaluation and management of penetrating lower extremity arterial trauma
2012
Follow-up After Asymptomatic Penetrating Thoracic Injury: 3 Hours is Enough
2008
American firearm homicides: The impact of your neighbors
2019
Selective nonoperative management of blunt splenic injury
2012
Intra-abdominal packing with laparotomy pads and QuikClot™ during damage control laparotomy: A safety analysis
2016
The Effects of Intraoperative Hypothermia on Surgical Site Infection
2012
An evidence-based approach to patient selection for emergency department thoracotomy
2015
CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
1997
Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.
1995
Autologous Tumor Infiltrating T Cells Cytotoxic for Follicular Lymphoma Cells Can Be Expanded In Vitro
1997
Autologous Tumor Infiltrating T Cells Cytotoxic for Follicular Lymphoma Cells Can Be Expanded In Vitro
1997
Complications related to endoscopic retrograde cholangiopancreatography: a comprehensive clinical review.
2009
Nonoperative management of blunt hepatic injury
2012
Ex Vivo Generation of Human Anti–Pre-B Leukemia-Specific Autologous Cytolytic T Cells
1997